Damage-Free, Ultrasonic Cell Isolation from Retinal Pigment Epithelium (RPE) Monolayers
Damage-Free, Ultrasonic Cell Isolation from Retinal Pigment Epithelium (RPE) Monolayers
批准号:
10717828
负责人:
EUN SOK KIM
金额:
$56.68万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-01 至 2027-02-28
关键词:
AcousticsAgeAge related macular degenerationAreaAtrophicBiopsyCell SeparationCell TherapyCellsChromosomesClinicalClinical TrialsCollectionComplexDataDerivation procedureDeveloped CountriesDevelopmentDiameterEncapsulatedEpithelial CellsFingerprintFocused UltrasoundFunctional disorderGelGenesGoalsGraft RejectionHumanImmuneImplantIndividualInterruptionLiquid substanceMeasuresMethodsMicrofluidicsMicrospheresModelingMolecularMolecular AnalysisMolecular ProfilingNatureNeedlesOilsPathologyPatientsPersonsPhotoreceptorsPluripotent Stem CellsPolymerase Chain ReactionPopulationProductionProgressive DiseaseProtocols documentationQuality ControlRadiationReagentResearchRetinaRetinal DegenerationReverse TranscriptionShapesSolidSpottingsStem cell transplantStructure of retinal pigment epitheliumSurfaceSuspensionsTechnologyTemperatureTestingThinnessTransducersTransfectionTransplantationTumorigenicityUltrasonic TransducerUltrasonicsVariantVisual impairmentcell injurycostembryonic stem cellepithelial to mesenchymal transitionhuman embryonic stem cellimprovedinduced pluripotent stem cellmonolayernoveloperationparticlepluripotencypressurepreventregenerativescaffoldsingle-cell RNA sequencingstem cellssubretinal injectiontranscriptometranscriptome sequencingultrasoundwound healing
中文摘要
摘要
视网膜相关性黄斑变性(AMD)是导致老年人严重视力损害的主要原因
50个发达国家[1,2]。干细胞衍生的视网膜色素上皮(RPE)的移植是
目前是治疗视网膜变性和晚期非新生血管性AMD(NAMD)的有前景的方法[3- 4]。
6]。已经开发了许多方案用于从来自人的多能干细胞衍生RPE。
胚胎干细胞(hESC)或人诱导多能干细胞(iPSC)[7-12]。的质量控制
供体细胞是临床试验中细胞生产的基本要求。干细胞残留物和染色体
临床使用前必须检测长期培养过程中的数量变化。然而,股骨柄的质量控制
细胞残基(多能性)和干细胞致瘤性并非微不足道。从RPE中物理移除细胞
由于上皮-间充质转化,在培养期间单层将导致单层的营养不良
(EMT)和伤口愈合。在RPE植入物的分子谱分析中存在未满足的需求,其具有空间结构。
RNA测序(RNA-seq)。聚焦超声(FUS)为这一未满足的需求提供了解决方案,因为它可以
通过含有细胞的液滴从固体表面喷射细胞,
围绕喷射点的边缘。超声波通过液体和固体传播,FUS换能器
不必与细胞生长的基底物理接触。细胞的数量
由FUS换能器发射的能量取决于FUS的焦点尺寸,其可以非常小,并且非常小。
精确且可重复。此外,它是低成本的,并且有效地用于分离数十至数百个单细胞,
平行通过换能器阵列。满足未满足的需求,实现RPE细胞治疗
对于AMD,我们建议使用自聚焦声换能器(SFAT)进行无损伤、含细胞的
用于空间单细胞RNA-seq的从在薄固体支架上生长的RPE单层的液滴喷射。除了
对于RPE植入物生产的质量控制,SFAT前所未有的按需喷射能力,
微粒或细胞(直径为数十至数百微米)将为人类的免疫学研究开辟许多新的可能性。
空间分子细胞研究、基因转染、并置和操作。
英文摘要
Abstract
Age-related macular degeneration (AMD) is the leading cause of severe visual impairment in people over age
50 in developed countries [1,2]. Transplantation of stem cell derived retinal pigment epithelium (RPE) is
currently a promising method to treat retinal degeneration and advanced non-neovascular AMD (NNAMD) [3-
6]. Many protocols have been developed for the derivation of RPE from pluripotent stem cells from human
embryonic stem cells (hESC) or human induced pluripotent stem cell (iPSC) [7-12]. The quality control of
donor cells is a basic requirement for cell production in clinical trials. Stem cell residues and chromosome
number variation during long-term culture must be tested before clinical use. However, quality control for stem
cell residues (pluripotency) and stem cell tumorigenicity is not trivial. Physically removing cells from an RPE
monolayer during culture will result in hypotrophy of the monolayer due to epithelial-mesenchymal transition
(EMT) and wound healing. There is an unmet need in the molecular profiling of RPE implants with spatial
RNA sequencing (RNA-seq). A focused ultrasound (FUS) offers a solution to this unmet need, as it can
produce ejection of cells via cell-containing liquid droplets from a solid surface with minimum impact on the
edges surrounding the ejection spot. Ultrasound propagates through liquid and solid, and the FUS transducer
does not have to be in physical contact with the substrate where cells are grown. The number of cells that are
ejected by a FUS transducer depends on the focal size of the FUS, which can be very small, and is very
precise and repeatable. Further, it is low-cost and effective for isolating tens to hundreds of single-cells in
parallel through an array of transducers. To satisfy the unmet need and allow realization of RPE cell therapy
for AMD, we propose to use self-focusing acoustic transducers (SFATs) for damage-free, cell-containing
droplet ejection from RPE monolayers grown on thin solid scaffolds for spatial single-cell RNA-seq. Besides
for quality control in RPE implant production, the SFAT’s unprecedented capability of on-demand ejection of
microparticles or cells (of tens - hundreds of microns in diameter) will open up many new possibilities in
spatial molecular cell study, gene transfection, juxtaposition and manipulation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Wearable, Always-on Stethoscope for Early Detection of Asthma Attack
-
批准号:10665806
-
项目类别:
-
资助金额:$69.53万
-
财政年份:2022
-
负责人:EUN SOK KIM
-
依托单位:
Wearable, Always-on Stethoscope for Early Detection of Asthma Attack
-
批准号:10501924
-
项目类别:
-
资助金额:$73.25万
-
财政年份:2022
-
负责人:EUN SOK KIM
-
依托单位:
MEMS Acoustic Tweezers for Micromanipulation of Living Cells
-
批准号:10021674
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2019
-
负责人:EUN SOK KIM
-
依托单位:
MEMS Acoustic Tweezers for Micromanipulation of Living Cells
-
批准号:10245078
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2019
-
负责人:EUN SOK KIM
-
依托单位:
MEMS Acoustic Tweezers for Micromanipulation of Living Cells
-
批准号:9803092
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2019
-
负责人:EUN SOK KIM
-
依托单位:
MEMS Acoustic Tweezers for Micromanipulation of Living Cells
-
批准号:10473728
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2019
-
负责人:EUN SOK KIM
-
依托单位:
Ultrasonic Neural Stimulation for Neuromodulation Therapeutics
-
批准号:9524451
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2018
-
负责人:EUN SOK KIM
-
依托单位:
Ultrasonic Neural Stimulation for Neuromodulation Therapeutics
-
批准号:9899986
-
项目类别:
-
资助金额:$31.68万
-
财政年份:2018
-
负责人:EUN SOK KIM
-
依托单位:
On-Chip Protein Synthesis Based on Directional Droplet-Ejector Array
-
批准号:7938577
-
项目类别:
-
资助金额:$19.85万
-
财政年份:2009
-
负责人:EUN SOK KIM
-
依托单位:
On-Chip Protein Synthesis Based on Directional Droplet-Ejector Array
-
批准号:7708805
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2009
-
负责人:EUN SOK KIM
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: